Core Insights - The Ministry of Industry and Information Technology and the National Development and Reform Commission have announced the first batch of biomanufacturing pilot capacity construction platforms, with 43 units selected nationwide [1][2] - The Hangzhou Synthetic Biology Industry Pilot (Validation) Center, operated by Transfar Group in collaboration with state-owned capital, has been recognized as a representative platform in Zhejiang Province [1][2] Group 1: Platform Overview - The pilot center is located in the Xiaoshan Green Manufacturing Industrial Park and focuses on pilot validation and scale-up of synthetic biology technology, covering various fields such as biomanufactured chemicals, enzyme preparations, food, and additives [1][2] - The center aims to create a comprehensive platform integrating technology pilot testing, result validation, process scale-up, and industrial transformation [1][2] Group 2: Technological Capabilities - The center has developed a high-throughput biomanufacturing platform that integrates advanced analytical equipment such as liquid chromatography-mass spectrometry and PCR, enabling core capabilities in strain design, high-throughput testing, and process validation [2] - The application of AI technology in synthetic biology is being actively promoted to support process optimization and parameter control, forming a comprehensive pilot capacity system covering the entire synthetic biology process [2] Group 3: Strategic Goals and Achievements - Transfar Group's Vice President highlighted that being selected as a national pilot platform is a recognition of the company's leading role in continuous innovation and industrial transformation in the biomanufacturing sector [2] - The center has undertaken 11 pilot projects, providing valuable testing grounds for new technologies, processes, and products, effectively accelerating the conversion of scientific research achievements [2] - Future plans include enhancing pilot equipment and services, improving standardization and intelligence levels, and providing replicable models for the industrialization of synthetic biology technology, contributing to the high-quality development of the bio-economy [2]